Source: International Congress 2015 – Lung cancer pathology



Rating:

Share or cite this content

Citations should be made in the following way:
Egbert E.F. Smit (Amsterdam, Netherlands). A new WHO classification for lung cancer after 11 years: clinical implications. International Congress 2015 – Lung cancer pathology

Member's Comments

No comment yet.

Related content which might interest you: Clinical features of lung cancer cases: a fifteen years experience Source: Eur Respir J 2004; 24: Suppl. 48, 300s Year: 2004 Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002 Therapeutic approach in patients above 65 years with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004 New findings in the molecular biology of lung cancer: clinical application Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Slow-growing lung cancer as an emerging entity: from screening to clinical management Source: Eur Respir J 2013; 42: 1706-1722 Year: 2013 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Clinical, histological and molecular characteristics of lung cancer in patients under 30 years-old. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014 Year: 2014 Close surveillance strategy for early lung cancer: results of 15 years of observation Source: Annual Congress 2008 - New trends in interventional pulmonology Year: 2008 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Early lung cancer: Results of 17 years close surveillance in two high-risk cohorts Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 COVID-19 and the management of thoracic cancer patients: challenges and recommendations Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations Year: 2020 Implications of new lung adenocarcinoma classification for oncologists Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update Year: 2009 Prognostic relevance of the new lung cancer classification in operable stages Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science Year: 2014 Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002